AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ArcticZymes Technologies Director's Dealing 2016

Jul 1, 2016

Director's Dealing

Opens in your device viewer

Biotec Pharmacon - mandatory notification of trade

(Tromsø 1. July 2016) Svein Lien, CEO of Biotec Pharmacon has purchased 20.000

shares at NOK 11,00 per share via his fully owned company Spiralen Industrier

AS. After this transaction holds Svein Lien and associates 530.262 shares and

160.000 options in Biotec Pharmacon.

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.